CAS号:2854-32-2
品名:2-(1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基)-1-吗啉乙酮2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone
中文别名:2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基]-1-(4-吗啉基)乙酮;
英文别名:Lopac-I-151;IndomethacinMorpholinylamide;Tocris-1383;Indomethacinmorpholinamide;Indomethacinmorpholinylamide;2-Methyl-5-methoxy-3-indolyl-essigsaeure-amid;IMMA;Ethanone(2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl);BML-190;
分子式:C23H23ClN2O4
分子量:426.893
精确质量:426.135
Psa:60.77
MDL号:MFCD01317813
密度:1.31g/cm3
沸点:586.7ºC at 760mmHg
闪点:308.6ºC
折射率:1.624
储存条件:2-8ºC
蒸汽压:8.34E-17mmHg at 25°C
WGK Germany:3
海关编码:2934999090
简介:BML-190(Indomethacinmorpholinylamide)isadrugusedinscientificresearchthatactsasaselectiveCB2inverseagonist.BML-190isstructurallyderivedfromtheNSAIDindomethacinbuthasaquitedifferentbiologicalactivity.Theactivityproducedbythiscompoundisdisputed,withsomesourcesreferringtoitasaCB2agonistratherthananinverseagonist;thismayreflectanerrorinclassification,oralternativelyitmayproducedifferenteffectsindifferenttissues,andmoreresearchisrequiredtoresolvethisdispute.
G蛋白偶联受体&G蛋白